PMDA drug package insert
ノボラピッド30ミックス注 フレックスペン
PMDA Prescription drug · ノボ ノルディスク ファーマ株式会社 · package insert Nov 30, 2023
Key facts
| Brand names | ノボラピッド30ミックス注 フレックスペン |
|---|---|
| Nonproprietary names | インスリン アスパルト（遺伝子組換え） |
| Companies | 製造販売元／ノボ ノルディスク ファーマ株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 二相性プロタミン結晶性インスリンアナログ水性懸濁注射液 |
| Therapeutic category codes | 872492 |
| YJ codes | 2492415G2020 |
| Approval numbers | 21900AMX01196000 |
| Package insert edition | 第2版 |
| Package insert date | Nov 30, 2023 |
| PMDA document key | 620023_2492415G2020_1 |
| PMDA company code | 620023 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: